2 Authorisations granted for 4-tert-OPnEO
On 23 February 2023, the European Commission granted 2 Authorisations for the following substance:
The Authorisations are held by Wallac Oy and concern 2 Authorised uses:
-
Authorisation number REACH/23/5/0 approves the formulation of 4-tert-OPnEO (as Triton X-100) for use in the assay buffer for the GSP® Neonatal GALT kit used for the semi-quantitative determination of galactose-1-phosphate uridyl transferase (GALT) activity.
-
Authorisation number REACH/23/5/1 approves the use of 4-tert-OPnEO in the assay buffer of the GSP® Neonatal GALT kit used for the semi-quantitative determination of galactose-1-phosphate uridyl transferase (GALT) activity.